English
Deutsch
Log In
Password Login
or
Log in with Fraunhofer Smartcard
Research Outputs
Projects
Researchers
Institutes
Statistics
Fraunhofer-Gesellschaft
Home
Fraunhofer-Gesellschaft
Artikel
POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? Yes
Details
Full
Export
Statistics
Options
2019
Journal Article
Titel
POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? Yes
Author(s)
Prasse, A.
Zeitschrift
Chest
DOI
10.1016/j.chest.2019.03.026
Language
English
google-scholar
View Details
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM